GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hayat Pharmaceutical Industries Co (AMM:HPIC) » Definitions » EPS (Basic)

Hayat Pharmaceutical Industries Co (AMM:HPIC) EPS (Basic) : JOD0.35 (TTM As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Hayat Pharmaceutical Industries Co EPS (Basic)?

Hayat Pharmaceutical Industries Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was JOD0.05. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was JOD0.35.

Hayat Pharmaceutical Industries Co's EPS (Diluted) for the three months ended in Mar. 2025 was JOD0.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was JOD0.35.

Hayat Pharmaceutical Industries Co's EPS without NRI for the three months ended in Mar. 2025 was JOD0.05. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.35.

During the past 12 months, Hayat Pharmaceutical Industries Co's average EPS without NRIGrowth Rate was 36.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was -4.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Hayat Pharmaceutical Industries Co's highest 3-Year average EPS without NRI Growth Rate was 57.30% per year. The lowest was -12.30% per year. And the median was 10.10% per year.


Hayat Pharmaceutical Industries Co EPS (Basic) Historical Data

The historical data trend for Hayat Pharmaceutical Industries Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hayat Pharmaceutical Industries Co EPS (Basic) Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.38 0.37 0.25 0.33

Hayat Pharmaceutical Industries Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.06 0.03 0.21 0.05

Hayat Pharmaceutical Industries Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hayat Pharmaceutical Industries Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3.09-0)/9.500
=0.33

Hayat Pharmaceutical Industries Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.434-0)/9.500
=0.05

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hayat Pharmaceutical Industries Co  (AMM:HPIC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Hayat Pharmaceutical Industries Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hayat Pharmaceutical Industries Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hayat Pharmaceutical Industries Co Business Description

Traded in Other Exchanges
N/A
Address
Nile St. Al-Rajeeb, P.O. Box 1564, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. Its principal activity is producing human and veterinary in all its forms and medical stickers and stockings. The company is also involved in the production of medical supplies, body care lotions, cosmetics, and initiating marketing campaigns as well as import and export operations. It has developed and registered a hundred sixteen different dosage forms/pack sizes in the Jordan market representing fifty six different brands (molecules) in various therapeutic areas. Its products include Cardiovascular system, Infectious disease Dermatology, Gastrointestinal system, and Respiratory system.

Hayat Pharmaceutical Industries Co Headlines

No Headlines